Ben Zimmerman currently serves as Head of Global Forecasting and Business Analytics at Genmab, overseeing global forecasting and analytics across oncology, hematology, immunology, and inflammation. Prior to this role, Ben held various senior positions at Bristol Myers Squibb, including International Market Insights & Capabilities Senior Director, where leadership of teams across multiple regions focused on commercial revenue forecasting and market research. Earlier experience includes positions in oncology and virology forecasting at Bristol Myers Squibb, as well as a Business Consulting Manager role at ZS, where skills in forecasting, analytics, and market research were developed. Ben holds a Bachelor’s degree in Physics from the University of Chicago.
This person is not in any offices